NDC 68462-311
teriflunomide
Teriflunomide
teriflunomide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Teriflunomide.
| Product ID | 68462-311_547ff1b7-72fc-4820-b337-d8ee0202fefe |
| NDC | 68462-311 |
| Product Type | Human Prescription Drug |
| Proprietary Name | teriflunomide |
| Generic Name | Teriflunomide |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-05-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209663 |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Substance Name | TERIFLUNOMIDE |
| Active Ingredient Strength | 7 mg/1 |
| Pharm Classes | Pyrimidine Synthesis Inhibitor [EPC],Dihydroorotate Dehydrogenase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |